|
CSE1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.063250E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.228600E-04 |
| Normal-vs-Stage2 |
1.431900E-02 |
| Normal-vs-Stage3 |
7.526600E-01 |
| Normal-vs-Stage4 |
3.906000E-01 |
| Stage1-vs-Stage2 |
8.000600E-01 |
| Stage1-vs-Stage3 |
6.480200E-02 |
| Stage1-vs-Stage4 |
1.895190E-01 |
| Stage2-vs-Stage3 |
1.552560E-01 |
| Stage2-vs-Stage4 |
3.064800E-01 |
| Stage3-vs-Stage4 |
7.683400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.323060E-03 |
| Normal-vs-AfricanAmerican |
3.540400E-03 |
| Normal-vs-Asian |
5.578000E-01 |
| Caucasian-vs-AfricanAmerican |
8.397600E-01 |
| Caucasian-vs-Asian |
4.727000E-01 |
| AfricanAmerican-vs-Asian |
3.384000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.07880000000693E-05 |
| Normal-vs-Female |
7.723000E-01 |
| Male-vs-Female |
1.109499999985E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.091600E-02 |
| Normal-vs-Extreme_Weight |
2.09510000004354E-06 |
| Normal-vs-Obese |
6.627700E-02 |
| Normal-vs-Extreme_Obese |
2.783700E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.692500E-02 |
| Normal_Weight-vs-Obese |
7.678400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.292000E-02 |
| Extreme_Weight-vs-Obese |
9.038500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.829000E-01 |
| Obese-vs-Extreme_Obese |
6.503800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.327200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.486480E-02 |
| Normal-vs-Age(61-80Yrs) |
1.197250E-04 |
| Normal-vs-Age(81-100Yrs) |
8.49240000000417E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.301600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.284300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.658400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.500100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.757600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.759700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.23649999994591E-06 |
| Normal-VS-Type2 PRCC |
3.501500E-03 |
| Normal-VS-KIRP CIMP |
2.865200E-01 |
| Normal-VS-Unclassified PRCC |
6.306000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.720360E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.386400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.686270E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.266000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.565700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.815190E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.402600E-04 |
| Normal-vs-N1 |
2.150800E-01 |
| Normal-vs-N2 |
2.419400E-01 |
| N0-vs-N1 |
1.257980E-03 |
| N0-vs-N2 |
6.073800E-01 |
| N1-vs-N2 |
2.421000E-01 |
|
|
